A randomized, placebo-controlled, trial to assess safety, tolerability, and immunogenicity of influenza virus vaccine, trivalent, types A & B, live cold-adapted (FluMist) and measles, mumps, rubella, (MMRII) and varicella (VARIVAXO) vaccines administered concurrently to healthy children (AV018)
Phase of Trial: Phase III
Latest Information Update: 01 Mar 2008
At a glance
- Drugs Influenza virus vaccine live; Measles mumps and rubella virus vaccine; Varicella zoster virus vaccine live
- Indications Chickenpox; Influenza A virus infections; Influenza virus infections; Measles; Mumps; Rubella
- Focus Pharmacodynamics
- 07 Feb 2008 Status changed from in progress to completed.
- 05 Nov 2005 New trial record.